HUTCHMED (Germany) Today
| H7T2 Stock | EUR 2.72 0.10 3.55% |
Performance0 of 100
| Odds Of DistressLess than 25
|
HUTCHMED is trading at 2.72 as of the 20th of December 2024. This is a 3.55% down since the beginning of the trading day. The stock's lowest day price was 2.72. HUTCHMED has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 26th of November 2023 and ending today, the 20th of December 2024. Click here to learn more.
HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases worldwide. HUTCHMED Limited was incorporated in 2000 and is headquartered in Central, Hong Kong. HUTCHMED operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. The company has 864.77 M outstanding shares. More on HUTCHMED LS 1
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
HUTCHMED Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. HUTCHMED's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding HUTCHMED or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Christian Hogg |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
HUTCHMED LS 1 (H7T2) is traded on Frankfurt Exchange in Germany and employs 2,110 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HUTCHMED's market, we take the total number of its shares issued and multiply it by HUTCHMED's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. HUTCHMED LS 1 operates under Healthcare sector and is part of Biotechnology industry. The entity has 864.77 M outstanding shares.
HUTCHMED LS 1 has accumulated about 950.45 M in cash with (105.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.13.
Check HUTCHMED Probability Of Bankruptcy
Ownership AllocationHUTCHMED LS 1 has a total of 864.77 Million outstanding shares. Over half of HUTCHMED's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Accordingly, these institutions are subject to different rules and regulations than regular investors in HUTCHMED LS 1. Please watch out for any change in the institutional holdings of HUTCHMED as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check HUTCHMED Ownership Details
HUTCHMED LS 1 Risk Profiles
Although HUTCHMED's alpha and beta are two of the key measurements used to evaluate HUTCHMED's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.98 | |||
| Semi Deviation | 3.09 | |||
| Standard Deviation | 4.05 | |||
| Variance | 16.39 |
HUTCHMED Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in HUTCHMED without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
HUTCHMED Corporate Management
Elected by the shareholders, the HUTCHMED's board of directors comprises two types of representatives: HUTCHMED inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HUTCHMED. The board's role is to monitor HUTCHMED's management team and ensure that shareholders' interests are well served. HUTCHMED's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HUTCHMED's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edith Shih | Company Secretary, Non-Executive Director | Profile | |
| May Wang | Senior Vice President - business development & strategic alliances | Profile | |
| Mark Lee | Senior Vice President - Corporate Finance & Development | Profile | |
| Karen Ferrante | Independent Non-Executive Director | Profile | |
| Weiguo Su | Chief Scientific Officer, Executive Director | Profile |
Other Information on Investing in HUTCHMED Stock
HUTCHMED financial ratios help investors to determine whether HUTCHMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HUTCHMED with respect to the benefits of owning HUTCHMED security.